tiprankstipranks
F-star Therapeutics (DE:S4BA)
FRANKFURT:S4BA

F-star Therapeutics (S4BA) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
2Neutral
3Bearish
Technical Analysis Consensus
Buy
5Bullish
0Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
2Neutral
0Bearish
F-star Therapeutics’s (S4BA) Moving Averages Convergence Divergence (MACD) indicator is 0.10, suggesting F-star Therapeutics is a Buy.
F-star Therapeutics’s (S4BA) 20-Day exponential moving average is 6.61, while F-star Therapeutics’s (S4BA) share price is €6.65, making it a Buy.
F-star Therapeutics’s (S4BA) 50-Day exponential moving average is 6.26, while F-star Therapeutics’s (S4BA) share price is €6.65, making it a Buy.

F-star Therapeutics (S4BA) Pivot Points

Jul 19, 2024, 07:31 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.38
6.52
6.58
6.72
6.78
6.92
6.98
Fibonacci
6.52
6.59
6.64
6.72
6.79
6.84
6.92
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

F-star Therapeutics (S4BA) Moving Averages

Jul 19, 2024, 07:31 PM
Period
Simple
Exponential
MA5
6.65Neutral
6.65Buy
MA10
6.65Neutral
6.65Buy
MA20
6.65Buy
6.61Buy
MA50
6.17Buy
6.26Buy
MA100
5.69Buy
5.90Buy
MA200
5.73Buy
5.63Buy
F-star Therapeutics’s (S4BA) 10-Day exponential moving average is 6.65, while F-star Therapeutics’s (S4BA) share price is €6.65, making it a Buy.
F-star Therapeutics’s (S4BA) 100-Day exponential moving average is 5.90, while F-star Therapeutics’s (S4BA) share price is €6.65, making it a Buy.
F-star Therapeutics’s (S4BA) stock price is €6.65 and F-star Therapeutics’s (S4BA) 50-day simple moving average is 6.17, creating a Buy signal.
F-star Therapeutics’s (S4BA) stock price is €6.65 and F-star Therapeutics’s (S4BA) 100-day simple moving average is 5.69, creating a Buy signal.
F-star Therapeutics’s (S4BA) stock price is €6.65 and F-star Therapeutics’s (S4BA) 200-day simple moving average is 5.73, creating a Buy signal.

F-star Therapeutics (S4BA) Technical Indicators

Jul 19, 2024, 07:31 PM
Name
Value
Implied Action
RSI (14)
74.44
Sell
STOCH (9,6)
<0.01
Buy
STOCHRSI (14)
<0.01
Buy
MACD (12,26)
0.10
Buy
ADX (14)
52.92
Sell
Williams %R
-100.00
Buy
CCI (14)
0.00
-
ATR (14)
0.21
-
Ultimate Oscillator
>-0.01
Sell
ROC
0.00
-
F-star Therapeutics’s (S4BA) Relative Strength Index (RSI) is 74.44, creating a Sell signal.
F-star Therapeutics’s (S4BA) Trend Strength Indicator (ADX) is 52.92, creating a Sell signal.

FAQ

Is S4BA a Buy, Hold, or Sell?
Based on S4BA’s technical indicators, S4BA is a Strong Buy.
    What is S4BA’s RSI (14)?
    S4BA’s RSI (14) is 74.44, which suggests S4BA is a Sell.
      What is S4BA’s MACD?
      S4BA’s MACD is 0.10, which suggests S4BA is a Buy.
        What is S4BA’s 5-day moving average?
        S4BA’s 5-day moving average is 6.65, which suggests S4BA is a Neutral.
          What is S4BA’s 20-day moving average?
          S4BA 20-day moving average is 6.65, which suggests S4BA is a Buy.
            What is S4BA’s 50-day moving average?
            S4BA’s 50-day moving average is 6.17, which suggests S4BA is a Buy.
              What is S4BA’s 200-day moving average?
              S4BA’s 200-day moving average is 5.73, which suggests S4BA is a Buy.
                What is S4BA’s Williams % R (14)?
                S4BA’s Williams % R (14) is -100.00, which suggests S4BA is a Buy.
                  What is S4BA’s CCI (14)?
                  Currently, no data Available
                  What is the share price of F-star Therapeutics?
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis